By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Upsher-Smith Laboratories, Inc. 

14905 23rd Avenue North

Minneapolis  Minnesota  55447  U.S.A.
Phone: 800-328-3344 Fax:


SEARCH JOBS








Company News
Upsher-Smith Laboratories Continues To Expand Generic Product Portfolio 11/8/2016 11:41:51 AM
Upsher-Smith Laboratories Presents Data Characterizing The Pharmacokinetics And Safety/Tolerability Of Investigational Midazolam Nasal Spray (Usl261) In Pediatric Participants With Epilepsy 10/28/2016 11:52:29 AM
Upsher-Smith Laboratories Acquires 20 Generic Drug Products 10/18/2016 8:02:29 AM
Upsher-Smith Laboratories Enters Into Exclusive Development And Distribution Agreement With Pharmathen 9/27/2016 7:22:52 AM
Upsher-Smith Laboratories Launches "It's That Simple" Program For Qudexy XR (topiramate) Extended-Release Capsules 9/8/2016 10:26:02 AM
Upsher-Smith Laboratories Enters Into Exclusive Marketing And Distribution Agreement With Emerging Pharmaceutical Company 8/25/2016 9:42:27 AM
Upsher-Smith Laboratories Wins Prestigious DIANA Award From Healthcare Distribution Alliance 6/30/2016 10:49:06 AM
Upsher-Smith Laboratories Granted Tentative FDA Approval For Qudexy XR (topiramate) Extended-Release Capsules For Prophylaxis Of Migraine Headache In Adults 6/10/2016 8:11:41 AM
Upsher-Smith Laboratories Announces Start Of First In Human Clinical Trial In Oncology With Novel CXCR4 Antagonist USL311 5/16/2016 7:25:38 AM
ANDROXY (Fluoxymesterone Tablets, USP) CIII Available Exclusively Through Upsher-Smith Laboratories 4/25/2016 7:28:00 AM
12345678910...
//-->